PEA-15 potentiates H-Ras-mediated epithelial cell transformation through phospholipase D

Oncogene

Volumn 31, Issue 30, 2012, Pages 3547-3560

  Sulzmaier, F J ^a,b   Valmiki, M K G ^a,b   Nelson, D A ^c   Caliva, M J ^a,d   Geerts, D ^e   Matter, M L ^d   White, E P ^c   Ramos, J W ^a,b  

^a UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^b UNIVERSITY OF HAWAII   (United States)

^c RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^d UNIVERSITY OF HAWAII   (United States)

^e SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

cell cycle; cell transformation; H Ras; PEA 15; PLD

Indexed keywords

COMPLEMENTARY DNA; CYCLIN D; CYCLIN DEPENDENT KINASE 4; GUANOSINE TRIPHOSPHATASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOLIPASE D; PHOSPHOPROTEIN; PHOSPHOPROTEIN ENRICHED IN ASTROCYTES 15KDA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; EPITHELIUM CELL; GENE MUTATION; KIDNEY EPITHELIUM; MOUSE; NONHUMAN; ONCOGENE H RAS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTO ONCOGENE; SIGNAL TRANSDUCTION; TUMOR GROWTH;

ANIMALS; CELL LINE; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; ENZYME INHIBITORS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY; MAP KINASE SIGNALING SYSTEM; MICE; MICE, NUDE; PHOSPHOLIPASE D; PHOSPHOPROTEINS; PROTO-ONCOGENE PROTEINS P21(RAS);

PISUM SATIVUM;

EID: 84864350270     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.514     Document Type: Article

References (50)

1. Barrett T, Troup DB, Wilhite SE, Ledoux P, Rudnev D, Evangelista C et al. (2009). NCBI GEO: archive for high-throughput functional genomic data. Nucleic Acids Res 37: D885-D890.
2. Bartholomeusz C, Rosen D, Wei C, Kazansky A, Yamasaki F, Takahashi T et al. (2008). PEA-15 induces autophagy in human ovarian cancer cells and is associated with prolonged overall survival. Cancer Res 68: 9302-9310.
3. Buchanan FG, McReynolds M, Couvillon A, Kam Y, Holla VR, Dubois RN et al. (2005). Requirement of phospholipase D1 activity in H-RasV12-induced transformation. Proc Natl Acad Sci USA 102: 1638-1642. (Pubitemid 40209220)
4. Castaneda CA, Cortes-Funes H, Gomez HL, Ciruelos EM. (2010). The phosphatidylinositol 3-kinase/AKT signaling pathway in breast cancer. Cancer Metastasis Rev 29: 751-759.
5. Connell-Crowley L, Harper JW, Goodrich DW. (1997). Cyclin D1/CDk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation. Mol Biol Cell 8: 287-301. (Pubitemid 27097944)
6. Cordova-Alarcon E, Centeno F, Reyes-Esparza J, Garcia-Carranca A, Garrido E. (2005). Effects of HRAS oncogene on cell cycle progression in a cervical cancer-derived cell line. Arch Med Res 36: 311-316. (Pubitemid 40798382)
7. Degenhardt K, White E. (2006). A mouse model system to genetically dissect the molecular mechanisms regulating tumorigenesis. Clin Cancer Res 12: 5298-5304. (Pubitemid 44497242)
8. Donaldson JG. (2009). Phospholipase D in endocytosis and endosomal recycling pathways. Biochim Biophys Acta 1791: 845-849.
9. Doti N, Cassese A, Marasco D, Paturzo F, Sabatella M, Viparelli F et al. (2010). Residues 762-801 of PLD1 mediate the interaction with PED/PEA15. Mol Biosyst 6: 2039-2048.
10. Dunn KL, Espino PS, Drobic B, He S, Davie Jr. (2005). The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling. Biochem Cell Biol 83: 1-14. (Pubitemid 40637962)
11. Ferro E, Trabalzini L. (2010). RalGDS family members couple Ras to Ral signalling and that0s not all. Cell Signal 22: 1804-1810.
12. Formisano P, Perruolo G, Libertini S, Santopietro S, Troncone G, Raciti GA et al. (2005). Raised expression of the antiapoptotic protein ped/pea-15 increases susceptibility to chemically induced skin tumor development. Oncogene 24: 7012-7021. (Pubitemid 41573630)
13. Formstecher E, Ramos JW, Fauquet M, Calderwood DA, Hsieh JC, Canton B et al. (2001). PEA-15 mediates cytoplasmic sequestration of ERK MAP kinase. Dev Cell 1: 239-250. (Pubitemid 33653059)
14. Frankel P, Ramos M, Flom J, Bychenok S, Joseph T, Kerkhoff E et al. (1999). Ral and Rho-dependent activation of phospholipase D in v-Raf-transformed cells. Biochem Biophys Res Commun 255: 502-507. (Pubitemid 29292289)
15. Haling JR, Wang F, Ginsberg MH. (2010). Phosphoprotein enriched in astrocytes 15 kDa (PEA-15) reprograms growth factor signaling by inhibiting threonine phosphorylation of fibroblast receptor substrate 2alpha. Mol Biol Cell 21: 664-673.
16. Hancock JF. (2007). PA promoted to manager. Nat Cell Biol 9: 615-617. (Pubitemid 47214719)
17. Joseph T, Bryant A, Frankel P, Wooden R, Kerkhoff E, Rapp UR et al. (2002). Phospholipase D overcomes cell cycle arrest induced by high-intensity Raf signaling. Oncogene 21: 3651-3658. (Pubitemid 34587697)
18. Joseph T, Wooden R, Bryant A, Zhong M, Lu Z, Foster DA. (2001). Transformation of cells overexpressing a tyrosine kinase by phospholipase D1 and D2. Biochem Biophys Res Commun 289: 1019-1024. (Pubitemid 34076291)
19. Lavoie JN, L0Allemain G, Brunet A, Muller R, Pouyssegur J. (1996). Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J Biol Chem 271: 20608-20616. (Pubitemid 26281839)
20. Lazarov M, Kubo Y, Cai T, Dajee M, Tarutani M, Lin Q et al. (2002). CDK4 coexpression with Ras generates malignant human epidermal tumorigenesis. Nat Med 8: 1105-1114. (Pubitemid 35175965)
21. Lin HJ, Eviner V, Prendergast GC, White E. (1995). Activated H-ras rescues E1A-induced apoptosis and cooperates with E1A to overcome p53-dependent growth arrest.Mol Cell Biol 15: 4536-4544.
22. Lovec H, Sewing A, Lucibello FC, Muller R, Moroy T. (1994). Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras: link between cell cycle control and malignant transformation. Oncogene 9: 323-326. (Pubitemid 24020966)
23. Lu Z, Hornia A, Joseph T, Sukezane T, Frankel P, Zhong M et al. (2000). Phospholipase D and RalA cooperate with the epidermal growth factor receptor to transform 3Y1 rat fibroblasts. Mol Cell Biol 20: 462-467. (Pubitemid 30023087)
24. Macaluso M, Russo G, Cinti C, Bazan V, Gebbia N, Russo A. (2002). Ras family genes: an interesting link between cell cycle and cancer. J Cell Physiol 192: 125-130. (Pubitemid 34747780)
25. Nandan MO, Yoon HS, ZhaoW, Ouko LA, Chanchevalap S, Yang VW. (2004). Kruppel-like factor 5 mediates the transforming activity of oncogenic H-ras. Oncogene 23: 3404-3413. (Pubitemid 38669830)
26. Noh DY, Ahn SJ, Lee RA, Park IA, Kim JH, Suh PG et al. (2000). Overexpression of phospholipase D1 in human breast cancer tissues. Cancer Lett 161: 207-214.
27. Pastorino S, Renganathan H, Caliva MJ, Filbert EL, Opoku-Ansah J, Sulzmaier FJ et al. (2010). The death effector domain protein PEA-15 negatively regulates T-cell receptor signaling. FASEB J 24: 2818-2828.
28. Radig K, Schneider-Stock R, Rose I, Mittler U, Oda Y, Roessner A. (1998). p53 and ras mutations in Ewing0s sarcoma. Pathol Res Pract 194: 157-162. (Pubitemid 28192782)
29. Ramos JW. (2008). The regulation of extracellular signal-regulated kinase (ERK) in mammalian cells. Int J Biochem Cell Biol 40: 2707-2719.
30. Ramos JW, Hughes PE, Renshaw MW, Schwartz MA, Formstecher E, Chneiweiss H et al. (2000). Death effector domain protein PEA-15 potentiates Ras activation of extracellular signal receptor-activated kinase by an adhesion-independent mechanism. Mol Biol Cell 11: 2863-2872. (Pubitemid 32107070)
31. Renganathan H, Vaidyanathan H, Knapinska A, Ramos JW. (2005). Phosphorylation of PEA-15 switches its binding specificity from ERK/MAPK to FADD. Biochem J 390: 729-735. (Pubitemid 41395356)
32. Revet I, Huizenga G, Chan A, Koster J, Volckmann R, van Sluis P et al. (2008). The MSX1 homeobox transcription factor is a downstream target of PHOX2B and activates the Delta-Notch pathway in neuroblastoma. Exp Cell Res 314: 707-719.
33. Rizzo MA, Shome K, Watkins SC, Romero G. (2000). The recruitment of Raf-1 to membranes is mediated by direct interaction with phosphatidic acid and is independent of association with Ras. J Biol Chem 275: 23911-23918. (Pubitemid 30624680)
34. Sathyan KM, Nalinakumari KR, Kannan S. (2007). H-ras mutation modulates the expression of major cell cycle regulatory proteins and disease prognosis in oral carcinoma. Mod Pathol 20: 1141-1148. (Pubitemid 47609061)
35. Scott SA, Selvy PE, Buck JR, Cho HP, Criswell TL, Thomas AL et al. (2009). Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness. Nat Chem Biol 5: 108-117.
36. Shi M, Zheng Y, Garcia A, Xu L, Foster DA. (2007). Phospholipase D provides a survival signal in human cancer cells with activated H-ras or K-Ras. Cancer Lett 258: 268-275. (Pubitemid 350101020)
37. Streit M, Velasco P, Brown LF, Skobe M, Richard L, Riccardi L et al. (1999). Overexpression of thrombospondin-1 decreases angiogenesis and inhibits the growth of human cutaneous squamous cell carcinomas. Am J Pathol 155: 441-452. (Pubitemid 29370394)
38. Tan TT, Degenhardt K, Nelson DA, Beaudoin B, Nieves-Neira W, Bouillet P et al. (2005). Key roles of BIM-driven apoptosis in epithelial tumors and rational chemotherapy. Cancer Cell 7: 227-238. (Pubitemid 40568682)
39. Uchida N, Okamura S, Kuwano H. (1999). Phospholipase D activity in human gastric carcinoma. Anticancer Res 19: 671-675. (Pubitemid 29168314)
40. Uchida N, Okamura S, Nagamachi Y, Yamashita S. (1997). Increased phospholipase D activity in human breast cancer. J Cancer Res Clin Oncol 123: 280-285. (Pubitemid 27230904)
41. Vaidyanathan H, Opoku-Ansah J, Pastorino S, Renganathan H, Matter ML, Ramos JW. (2007). ERK MAP kinase is targeted to RSK2 by the phosphoprotein PEA-15. Proc Natl Acad Sci USA 104: 19837-19842.
42. Viparelli F, Cassese A, Doti N, Paturzo F, Marasco D, Dathan NA et al. (2008). Targeting of PED/PEA-15 molecular interaction with phospholipase D1 enhances insulin sensitivity in skeletal muscle cells. J Biol Chem 283: 21769-21778.
43. Waber PG, Chen J, Nisen PD. (1993). Infrequency of ras, P53, WT1, or RB gene alterations in Wilms tumors. Cancer 72: 3732-3738. (Pubitemid 24000612)
44. Wang HG, Pathan N, Ethell IM, Krajewski S, Yamaguchi Y, Shibasaki F et al. (1999). Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD. Science 284: 339-343. (Pubitemid 129523456)
45. Whitehurst AW, Robinson FL, Moore MS, Cobb MH. (2004). The death effector domain protein PEA-15 prevents nuclear entry of ERK2 by inhibiting required interactions. J Biol Chem 279: 12840-12847. (Pubitemid 38445857)
46. Yang H, Masters SC, Wang H, Fu H. (2001). The proapoptotic protein Bad binds the amphipathic groove of 14-3-3zeta. Biochim Biophys Acta 1547: 313-319. (Pubitemid 32532149)
47. Zeng X, Shaikh FY, Harrison MK, Adon AM, Trimboli AJ, Carroll KA et al. (2010). The Ras oncogene signals centrosome amplification in mammary epithelial cells through cyclin D1/CDk4 and Nek2. Oncogene 29: 5103-5112.
48. Zhang Y, Redina O, Altshuller YM, Yamazaki M, Ramos J, Chneiweiss H et al. (2000). Regulation of expression of phospholipase D1 and D2 by PEA-15, a novel protein that interacts with them. J Biol Chem 275: 35224-35232.
49. Zhao C, Du G, Skowronek K, Frohman MA, Bar-Sagi D. (2007). Phospholipase D2-generated phosphatidic acid couples EGFR stimulation to Ras activation by Sos. Nat Cell Biol 9: 706-712.
50. Zhao Y, Ehara H, Akao Y, Shamoto M, Nakagawa Y, Banno Y et al. (2000). Increased activity and intranuclear expression of phospholipase D2 in human renal cancer. Biochem Biophys Res Commun 278: 140-143.